Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health
Lloyd Price
AUGUST 5, 2023
Allurion's gastric balloon is FDA-approved and has been shown to be effective in helping people lose weight. Here are some of the key takeaways from Allurion's IPO: The company's gastric balloon is a non-surgical weight loss device that is FDA-approved. Additionally, the company has been criticized for its high price tag.
Let's personalize your content